News | March 17, 2015

NorthStar Medical Radioisotopes to Unveil Commercial Model of RadioGenix Isotope Separation System

System automates on-site isotope separation processes with enhanced safety features

NorthStar, RadioGenix, isotopes, separation system, Tc-99m

Image courtesy of NorthStar Medical Radioisotopes LLC

March 17, 2015 — NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope separation system during three events on March 27 and March 28 at The Keating Hotel in San Diego. The events will be the first public demonstrations of system enhancements directly inspired by recommendations made by nuclear pharmacists during similar events last year.

The RadioGenix — which is currently under consideration by the U.S. Food and Drug Administration and which NorthStar plans to introduce to the market in the near future — will create the United States’ first domestic supply of technetium-99m (Tc-99m) in more than 45 years. Technetium-99m is the most widely used radioisotope in medical diagnostic imaging. The RadioGenix system will produce high specific activity Tc-99m from low specific activity molybdenum-99 (Mo-99).

NorthStar has two proprietary processes for producing Mo-99 in the United States without the use of highly enriched uranium (HEU). These processes may well overcome the chronic shortage of this critical isotope that has plagued the nuclear medicine industry for a half-dozen years. Currently, nearly all Mo-99 is generated using weapons-useable HEU at aging facilities located outside of the United States, leading to product shortages and creating safety and national security concerns.

The RadioGenix system automates the on-site isotope separation process and includes safety features that are absent from all other systems currently on the market. These features include periodic on-site sterilization of fluid pathways, disposable sterility filters and an automated filter integrity test prior to each elution.

During the unveiling events, company executives and service engineers will provide demonstrations and discuss enhancements made to the system over the past year. The improvements – most notably to the source vessel containment unit, the stainless steel covering and the liquid phase sterilization unit – are direct responses to recommendations made by nuclear pharmacists who saw a developmental model of the system during last year’s events.

Event attendees can also learn more about the early adopter program that NorthStar expects to begin later in 2015

For more information: www.northstarnm.com

Related Content

United Imaging Announces First U.S. Clinical Installation of uExplorer Total-body PET/CT
News | PET-CT | August 15, 2019
United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system...
ASRT Supports Radiopharmaceutical Reimbursement Bill
News | Radiopharmaceuticals and Tracers | August 02, 2019
The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) 3772, a measure...
International Multidisciplinary Group Publishes Recommendations for Personalized HCC Treatment With Y90 TheraSphere
News | Interventional Radiology | July 31, 2019
New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s TheraSphere have...
NorthStar Medical Radioisotopes Awarded $30 Million by U.S. Department of Energy
News | Radiopharmaceuticals and Tracers | July 26, 2019
NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U.S. Department of...
NorthStar Medical Radioisotopes Completes Construction on Beloit, Wis. Molybdenum-99 Processing Facility
News | Radiopharmaceuticals and Tracers | July 16, 2019
NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot molybdenum-99 (Mo-...
Bracco Imaging Acquires Blue Earth Diagnostics
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
United Imaging Announces First U.S. Clinical Install of uMI 550 Digital PET/CT System
News | PET-CT | June 19, 2019
United Imaging announced the first U.S. clinical installation of the uMI 550 Digital positron emission tomography/...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...